An in-house therapeutic area team with extensive knowledge and experience in GLP-1 biology, pharmacology, and clinical research, which allows us to provide valuable insights and tailored support throughout all stages of GLP-1 research.
A leading CRO partner in diabetes clinical research with hands-on experience and KOL resources, supported by a network of industry experts and academic organization.
Leveraging innovative technologies like hybrid model of remote + onsite monitoring, as well as comprehensive approaches to effectively manage complex GLP-1 clinical trials.
Therapeutic Expertise
Diabetes, Obesity, Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Chronic Kidney Disease, etc.